Brief: Collegium Announces Fourth Quarter And Full Year 2022 Preliminary Financial Results
Feb 6 (Reuters) - Collegium Pharmaceutical Inc COLL.O :
* COLLEGIUM ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022
PRELIMINARY FINANCIAL RESULTS
* SEES Q4 PRODUCT REVENUES IN RANGE OF $125.7 MILLION TO
$128.2
MILLION
* SEES Q4 ADJUSTED EBITDA IN RANGE OF $71.9 MILLION TO
$74.4
MILLION
* Q4 EARNINGS PER SHARE VIEW $-0.21, REVENUE VIEW $123.2
MILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5dSqQV
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%